Hillmann Petra

PIQUR Therapeutics AG

Claim

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 62 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Table S6 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

Chiara Tarantelli,Eugenio Gaudio,Alberto J. Arribas,Ivo Kwee,Petra Hillmann,Andrea Rinaldi,Luciano Cascione,Filippo Spriano,Elena Bernasconi,Francesca Guidetti,Laura Carrassa,Roberta Bordone Pittau,Florent Beaufils,Reto Ritschard,Denise Rageot,Alexander Sele,Barbara Dossena,Francesca Maria Rossi,Antonella Zucchetto,Monica Taborelli,Valter Gattei,Davide Rossi,Anastasios Stathis,Georg Stussi,Massimo Broggini,Matthias P. Wymann,Andreas Wicki,Emanuele Zucca,Vladimir Cmiljanovic,Doriano Fabbro,Francesco Bertoni

openalex（2023）

Cited0Views0Bibtex

Supplementary Figures, Table Legends, Table S1, S9 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Table S4 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Table S5 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Table S2 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Table S7 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Table S8 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Local Application of Engineered Insulin-Like Growth Factor I Mrna Demonstrates Regenerative Therapeutic Potential in Vivo

Justin S. Antony, Pascale Birrer, Claudia Bohnert, Sina Zimmerli,Petra Hillmann,Herve Schaffhauser,Christine Hoeflich,Andreas Hoeflich,Ramzi Khairallah, Andreas T. Satoh, Isabelle Kappeler, Isabel Ferreira,Klaas P. Zuideveld,Friedrich Metzger

MOLECULAR THERAPY NUCLEIC ACIDS（2023）

Cited1Views0WOSBibtex

Table S3 from PQR309 is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas As a Single Agent and in Combination Therapy

openalex（2023）

Cited0Views0Bibtex

Design of Combinatory RNA Molecules to Simultaneously Activate Tumor Immunity and Target Several Signaling Pathways in Solid Tumors

Petra Hillmann, Justin A. Selvaraj, Sina E. Zimmerli, Pascale G. Birrer, Claudia C. Bohnert,Klaas P. Zuideveld,Stefan J. Scherer

CANCER RESEARCH（2022）

Cited0Views0Bibtex

Author Statistics

#Papers: 62

#Citation: 1749

H-Index: 19

G-Index: 32

Sociability: 5

Diversity: 2

Activity: 2

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn